Anticholinergic Burden in Children, Adults and Older Adults in Slovenia: A Nationwide Database Study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Nishtala, P. S., Salahudeen, M. S. & Hilmer, S. N. Anticholinergics: theoretical and clinical overview. Expert. Opin. Drug. Saf. 15, 753–768 (2016).
UpToDate, electronic clinical resource tool, http://www.uptodate.com (2019).
West, T., Pruchnicki, M. C., Porter, K. & Emptage, R. Evaluation of anticholinergic burden of medications in older adults. J. Am. Pharm. Assoc. 53, 496–504 (2003).
Gray, S. L. et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern. Med. 175, 401–407 (2015).
Salahudeen, M. S. & Nishtala, P. S. Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research. Drugs Aging 33, 305–313 (2016).
Marcum, Z. A. et al. Anticholinergic Use and Recurrent Falls in Community-Dwelling Older Adults: Findings From the Health ABC Study. Ann. Pharmacother. 49, 1214–1221 (2015).
Gamble, D. T. et al. Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population. Int. J. Epidemiol. 47, 625–633 (2018).
Coupland, C. A. C. et al. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med 24 (2019).
Richardson, K. et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ 25 (2018).
Fox, C. et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J. Am. Geriatr. Soc. 59, 1477–1483 (2011).
Steel, Z. et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. Int. J. Epidemiol. 43, 476–493 (2014).
Landi, F. et al. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. J. Am. Med. Dir. Assoc. 15, 825–829 (2014).
Madden, K., Hussain, K. & Tasker, R. C. Anticholinergic Medication Burden in Pediatric Prolonged Critical Illness: A Potentially Modifiable Risk Factor for Delirium. Pediatr. Crit. Care Med. 19, 917–924 (2018).
Hong, I. S. & Bishop, J. R. Anticholinergic use in children and adolescents after initiation of antipsychotic therapy. Ann. Pharmacother. 44, 1171–1180 (2010).
Madden, K., Burns, M. M. & Tasker, R. C. Differentiating Delirium From Sedative/Hypnotic-Related Iatrogenic Withdrawal Syndrome: Lack of Specificity in Pediatric Critical Care Assessment Tools. Pediatr. Crit. Care Med. 18, 580–588 (2017).
Campbell, N., Maidment, I., Fox, C., Khan, B. & Boustani, M. The 2012 update to the anticholinergic cognitive burden scale. J. Am. Geriatr. Soc 61(No. S1), S142–S143 (2013).
Boustani, M., Campbell, N., Munger, S., Maidment, I. & Fox, C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health 4, 311–320 (2008).
Duran, C. E., Azermai, M. & Vander Stichele, R. H. Systematic review of anticholinergic risk scales in older adults. Eur. J. Clin. Pharmacol. 69, 1485–1496 (2013).
Gorup, E., Rifel, J. & Petek Ster, M. Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients. Zdr. Varst. 57, 140–147 (2018).
Fox, C. et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing 43, 604–615 (2014).
Anderson, S. L. & Vande Griend, J. P. Quetiapine for insomnia: A review of the literature. Am. J. Health Syst. Pharm. 71, 394–402 (2014).
American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 63, 2227–2246 (2015).
Trospium Chloride 20 mg Film-Coated Tablets. Summary of Product Characteristics, http://www.medicines.org.uk (2019).
Tolterodine tartrate 1 mg film-coated tablets. Summary of product characteristics, http://www.medicines.org.uk (2019).
Quetiapine 25mg film-coated tablets. Summary of product characteristics, http://www.medicines.org.uk (2019).
Salahudeen, M. S., Duffull, S. B. & Nishtala, P. S. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 15, 31, https://doi.org/10.1186/s12877-015-0029-9 (2015).
Kouladjian, L., Gnjidic, D., Reeve, E., Chen, T. F. & Hilmer, S. N. Health Care Practitioners’ Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults. Ann. Pharmacother. 50, 625–636 (2016).
Slovenian national health insurance annual report 2015. Published 2016, http://www.zzzs.si (2019).
PCNE Newsletter. 2017, http://www.pcne.org/upload/files/174_PCNE_news_2016-4.pdf (2019).
Jazbar, J., Locatelli, I., Horvat, N. & Kos, M. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study. Res. Soc. Adm. Pharm. 14, 572–580, https://doi.org/10.1016/j.sapharm.2017.07.004 (2018).
Mardetko, N. & Kos, M. Introduction of therapeutic reference pricing in Slovenia and its economic consequences. Eur. J. Health Econ. 19, 571–584, https://doi.org/10.1007/s10198-017-0903-9 (2018).
Welsh, T. J., van der Wardt, V., Ojo, G., Gordon, A. L. & Gladman, J. R. F. Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews. Drugs Aging 35, 523–538, https://doi.org/10.1007/s40266-018-0549-z (2018).
Lozano-Ortega, G. et al. A review of published anticholinergic scales and measures and their applicability in database analyses. Arch Gerontol Geriatr, https://doi.org/10.1016/j.archger.2019.05.010 (2019).